Results 241 to 250 of about 69,782 (261)

Novel insights into mesothelioma biology and implications for therapy

Nature Reviews Cancer, 2017
Sanjay Popat, Dean A Fennell
exaly  

Deep learning-based classification of mesothelioma improves prediction of patient outcome

Nature Medicine, 2019
Mikhail Zaslavskiy, Nolwenn Le Stang
exaly  

Malignant Pleural Mesothelioma

, 2017
Mónica Edith SernaCamacho, Seir Alfonso
semanticscholar   +1 more source

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

Nature Genetics, 2016
Raphael Bueno, Leonard D Goldstein, Steffen Durinck   +2 more
exaly  

Diagnosing Malignant Pleural Mesothelioma

Chest, 1998
openaire   +2 more sources

Germline BAP1 mutations predispose to malignant mesothelioma

Nature Genetics, 2011
Joseph R Testa, Jennifer E. Below, Yinfei Tan   +2 more
exaly  

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Nature Genetics, 2011
Matthew Bott, Marie Brevet, Lu Wang
exaly  

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Lancet, The, 2016
Gérard Zalcman, Julien Mazieres, Laurent Greillier   +2 more
exaly  

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

Lancet Oncology, The, 2017
Michele Maio, Arnaud Scherpereel, Joachim Aerts   +2 more
exaly  

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

Lancet Oncology, The, 2011
Tom Treasure, Suresh Senan, John G Edwards   +2 more
exaly